Evaluation of the analgesic and anti-inflammatory effects of a Brazilian green propolis

Abstract Phamacological activities of a standard ethanol extract G1 from Brazilian green propolis, typified as BRP1, was evaluated in mouse models of pain and inflammation. Intraperitoneal injection (I. P.) of G1 inhibited acetic acid-induced abdominal constrictions with an ID 50 = 0.75 ± 0.05 mg/kg...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Planta medica 2006-08, Vol.72 (10), p.899-906
Hauptverfasser: Paulino, N, Teixeira, C, Scremin, A, Dirsch, V.M, Vollmar, A.M, Abreu, S.R.L, Castro, S.L. de, Marcucci, M.C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 906
container_issue 10
container_start_page 899
container_title Planta medica
container_volume 72
creator Paulino, N
Teixeira, C
Scremin, A
Dirsch, V.M
Vollmar, A.M
Abreu, S.R.L
Castro, S.L. de
Marcucci, M.C
description Abstract Phamacological activities of a standard ethanol extract G1 from Brazilian green propolis, typified as BRP1, was evaluated in mouse models of pain and inflammation. Intraperitoneal injection (I. P.) of G1 inhibited acetic acid-induced abdominal constrictions with an ID 50 = 0.75 ± 0.05 mg/kg, and in the formalin test the ID 50 values were 0.85 ± 0.07 mg/kg and 13.88 ± 1.12 mg/kg, respectively, for the neurogenic and inflammatory phases. The extract was ineffective when assessed in the hot-plate assay. In serotonin-induced paw edema, G1 led to a maximal inhibition (MI) of 51.6 % after 120 min when administered I. P. and of 36 % after 15 min by the oral route (O. R.). When the inflammatory agent was complete Freund’s adjuvant, inhibition of paw edema was also observed after administration of the extract by both routes. In the capsaicin-induced ear edema the ID 50 values were 1.09 ± 0.08 mg/kg (I. P.) and 10.00 ± 0.90 mg/kg (O. R.). In the acute carrageenan-induced inflammatory reaction induced by carrageenan, G1 reduced the number of neutrophils in the peritoneal cavity with IC 50 values of 0.72 ± 0.08 mg/kg and 4.17 ± 0.50 mg/kg, by I. P. or O. R. administration, with a preferential migration of polymorphonuclear neutrophils. IN VITRO, G1 decreased nitric oxide production in LPS-stimulated RAW 264.7 cells (IC 50 = 41.60 μg/mL), and also the luciferase activity in TNF-α-stimulated HEK 293 cells transfected with NF-κB-luciferase reporter gene driven by the nuclear factor κB (NF-κB) (IC 50 = 200 μg/mL). This extract, which at low concentrations induces anti-inflammatory and analgesic effects in mouse models, presents a high content of flavonoids, known to inhibit inducible NOS (iNOS) activity. These data taken together led us to reinforce the hypothesis in the literature that the anti-inflammatory effect of propolis may be a due to inhibition of iNOS gene expression, through interference with NF-κB sites in the iNOS promoter.
doi_str_mv 10.1055/s-2006-947185
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68839734</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68839734</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-6a4aebd66e5feba73c4a99476a31fa04106bc146676ad6944a0049e2514fcf783</originalsourceid><addsrcrecordid>eNp10MFrFDEUBvAgit1Wj151Lnoy-jLJZCZHLa0KBQ9aPIa32ZdtSmayJjNC_evNMgs9eQgJ4cf7eB9jrwR8ENB1HwtvATQ3qhdD94RthJKGQ9uKp2wDIFsORskzdl7KPYBQBuA5OxPaQDt0w4b9uvqDccE5pKlJvpnvqMEJ455KcPW1q2cOPEw-4jjinPJDQ96Tm8uRY_M5498QA07NPhNNzSGnQ4qhvGDPPMZCL0_3Bbu9vvp5-ZXffP_y7fLTDXdq6GeuUSFtd1pT52mLvXQKTd1FoxQeQQnQWyeU1vVnp41SCKAMtZ1Q3vl-kBfs3Tq3Bv9eqMx2DMVRjDhRWorVwyBNL1WFfIUup1IyeXvIYcT8YAXYY5O22GOTdm2y-tenwct2pN2jPlVXwdsTwOIw-oyTC-XRDb3Qre6re7-6-S7QSPY-Lbk2XP6b-2blHpPFfa4jb3-0ICQIAT3U4H9G7ZJC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68839734</pqid></control><display><type>article</type><title>Evaluation of the analgesic and anti-inflammatory effects of a Brazilian green propolis</title><source>MEDLINE</source><source>Thieme Connect Journals</source><creator>Paulino, N ; Teixeira, C ; Scremin, A ; Dirsch, V.M ; Vollmar, A.M ; Abreu, S.R.L ; Castro, S.L. de ; Marcucci, M.C</creator><creatorcontrib>Paulino, N ; Teixeira, C ; Scremin, A ; Dirsch, V.M ; Vollmar, A.M ; Abreu, S.R.L ; Castro, S.L. de ; Marcucci, M.C</creatorcontrib><description>Abstract Phamacological activities of a standard ethanol extract G1 from Brazilian green propolis, typified as BRP1, was evaluated in mouse models of pain and inflammation. Intraperitoneal injection (I. P.) of G1 inhibited acetic acid-induced abdominal constrictions with an ID 50 = 0.75 ± 0.05 mg/kg, and in the formalin test the ID 50 values were 0.85 ± 0.07 mg/kg and 13.88 ± 1.12 mg/kg, respectively, for the neurogenic and inflammatory phases. The extract was ineffective when assessed in the hot-plate assay. In serotonin-induced paw edema, G1 led to a maximal inhibition (MI) of 51.6 % after 120 min when administered I. P. and of 36 % after 15 min by the oral route (O. R.). When the inflammatory agent was complete Freund’s adjuvant, inhibition of paw edema was also observed after administration of the extract by both routes. In the capsaicin-induced ear edema the ID 50 values were 1.09 ± 0.08 mg/kg (I. P.) and 10.00 ± 0.90 mg/kg (O. R.). In the acute carrageenan-induced inflammatory reaction induced by carrageenan, G1 reduced the number of neutrophils in the peritoneal cavity with IC 50 values of 0.72 ± 0.08 mg/kg and 4.17 ± 0.50 mg/kg, by I. P. or O. R. administration, with a preferential migration of polymorphonuclear neutrophils. IN VITRO, G1 decreased nitric oxide production in LPS-stimulated RAW 264.7 cells (IC 50 = 41.60 μg/mL), and also the luciferase activity in TNF-α-stimulated HEK 293 cells transfected with NF-κB-luciferase reporter gene driven by the nuclear factor κB (NF-κB) (IC 50 = 200 μg/mL). This extract, which at low concentrations induces anti-inflammatory and analgesic effects in mouse models, presents a high content of flavonoids, known to inhibit inducible NOS (iNOS) activity. These data taken together led us to reinforce the hypothesis in the literature that the anti-inflammatory effect of propolis may be a due to inhibition of iNOS gene expression, through interference with NF-κB sites in the iNOS promoter.</description><identifier>ISSN: 0032-0943</identifier><identifier>EISSN: 1439-0221</identifier><identifier>DOI: 10.1055/s-2006-947185</identifier><identifier>PMID: 16902858</identifier><identifier>CODEN: PLMEAA</identifier><language>eng</language><publisher>Stuttgart: Thieme</publisher><subject>analgesic effect ; Analgesics - isolation &amp; purification ; Analgesics - therapeutic use ; animal disease models ; Animals ; anti-inflammatory activity ; Anti-Inflammatory Agents - isolation &amp; purification ; Anti-Inflammatory Agents - therapeutic use ; Apoidea ; Biological and medical sciences ; Brazil ; Cell Line ; Chromatography, High Pressure Liquid ; cultured cells ; Drug Evaluation, Preclinical ; edema ; enzyme inhibition ; flavonoids ; Gene Expression Regulation - drug effects ; General pharmacology ; Humans ; Inflammation - drug therapy ; Male ; Medical sciences ; Mice ; neutrophils ; nitric oxide ; nitric oxide synthase ; Nitric Oxide Synthase Type II - genetics ; Nitric Oxide Synthase Type II - metabolism ; nitrites ; Original Paper ; Pain - drug therapy ; Pharmacognosy. Homeopathy. Health food ; Pharmacology. Drug treatments ; Plant Extracts - administration &amp; dosage ; Plant Extracts - isolation &amp; purification ; Plant Extracts - therapeutic use ; propolis ; Propolis - administration &amp; dosage ; Propolis - chemistry ; Propolis - therapeutic use ; signal transduction ; tumor necrosis factor-alpha</subject><ispartof>Planta medica, 2006-08, Vol.72 (10), p.899-906</ispartof><rights>Georg Thieme Verlag KG Stuttgart · New York</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-6a4aebd66e5feba73c4a99476a31fa04106bc146676ad6944a0049e2514fcf783</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2006-947185.pdf$$EPDF$$P50$$Gthieme$$H</linktopdf><linktohtml>$$Uhttps://www.thieme-connect.de/products/ejournals/html/10.1055/s-2006-947185$$EHTML$$P50$$Gthieme$$H</linktohtml><link.rule.ids>314,776,780,3004,3005,27901,27902,54534,54535</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18716267$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16902858$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paulino, N</creatorcontrib><creatorcontrib>Teixeira, C</creatorcontrib><creatorcontrib>Scremin, A</creatorcontrib><creatorcontrib>Dirsch, V.M</creatorcontrib><creatorcontrib>Vollmar, A.M</creatorcontrib><creatorcontrib>Abreu, S.R.L</creatorcontrib><creatorcontrib>Castro, S.L. de</creatorcontrib><creatorcontrib>Marcucci, M.C</creatorcontrib><title>Evaluation of the analgesic and anti-inflammatory effects of a Brazilian green propolis</title><title>Planta medica</title><addtitle>Planta Med</addtitle><description>Abstract Phamacological activities of a standard ethanol extract G1 from Brazilian green propolis, typified as BRP1, was evaluated in mouse models of pain and inflammation. Intraperitoneal injection (I. P.) of G1 inhibited acetic acid-induced abdominal constrictions with an ID 50 = 0.75 ± 0.05 mg/kg, and in the formalin test the ID 50 values were 0.85 ± 0.07 mg/kg and 13.88 ± 1.12 mg/kg, respectively, for the neurogenic and inflammatory phases. The extract was ineffective when assessed in the hot-plate assay. In serotonin-induced paw edema, G1 led to a maximal inhibition (MI) of 51.6 % after 120 min when administered I. P. and of 36 % after 15 min by the oral route (O. R.). When the inflammatory agent was complete Freund’s adjuvant, inhibition of paw edema was also observed after administration of the extract by both routes. In the capsaicin-induced ear edema the ID 50 values were 1.09 ± 0.08 mg/kg (I. P.) and 10.00 ± 0.90 mg/kg (O. R.). In the acute carrageenan-induced inflammatory reaction induced by carrageenan, G1 reduced the number of neutrophils in the peritoneal cavity with IC 50 values of 0.72 ± 0.08 mg/kg and 4.17 ± 0.50 mg/kg, by I. P. or O. R. administration, with a preferential migration of polymorphonuclear neutrophils. IN VITRO, G1 decreased nitric oxide production in LPS-stimulated RAW 264.7 cells (IC 50 = 41.60 μg/mL), and also the luciferase activity in TNF-α-stimulated HEK 293 cells transfected with NF-κB-luciferase reporter gene driven by the nuclear factor κB (NF-κB) (IC 50 = 200 μg/mL). This extract, which at low concentrations induces anti-inflammatory and analgesic effects in mouse models, presents a high content of flavonoids, known to inhibit inducible NOS (iNOS) activity. These data taken together led us to reinforce the hypothesis in the literature that the anti-inflammatory effect of propolis may be a due to inhibition of iNOS gene expression, through interference with NF-κB sites in the iNOS promoter.</description><subject>analgesic effect</subject><subject>Analgesics - isolation &amp; purification</subject><subject>Analgesics - therapeutic use</subject><subject>animal disease models</subject><subject>Animals</subject><subject>anti-inflammatory activity</subject><subject>Anti-Inflammatory Agents - isolation &amp; purification</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Apoidea</subject><subject>Biological and medical sciences</subject><subject>Brazil</subject><subject>Cell Line</subject><subject>Chromatography, High Pressure Liquid</subject><subject>cultured cells</subject><subject>Drug Evaluation, Preclinical</subject><subject>edema</subject><subject>enzyme inhibition</subject><subject>flavonoids</subject><subject>Gene Expression Regulation - drug effects</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Inflammation - drug therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>neutrophils</subject><subject>nitric oxide</subject><subject>nitric oxide synthase</subject><subject>Nitric Oxide Synthase Type II - genetics</subject><subject>Nitric Oxide Synthase Type II - metabolism</subject><subject>nitrites</subject><subject>Original Paper</subject><subject>Pain - drug therapy</subject><subject>Pharmacognosy. Homeopathy. Health food</subject><subject>Pharmacology. Drug treatments</subject><subject>Plant Extracts - administration &amp; dosage</subject><subject>Plant Extracts - isolation &amp; purification</subject><subject>Plant Extracts - therapeutic use</subject><subject>propolis</subject><subject>Propolis - administration &amp; dosage</subject><subject>Propolis - chemistry</subject><subject>Propolis - therapeutic use</subject><subject>signal transduction</subject><subject>tumor necrosis factor-alpha</subject><issn>0032-0943</issn><issn>1439-0221</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10MFrFDEUBvAgit1Wj151Lnoy-jLJZCZHLa0KBQ9aPIa32ZdtSmayJjNC_evNMgs9eQgJ4cf7eB9jrwR8ENB1HwtvATQ3qhdD94RthJKGQ9uKp2wDIFsORskzdl7KPYBQBuA5OxPaQDt0w4b9uvqDccE5pKlJvpnvqMEJ455KcPW1q2cOPEw-4jjinPJDQ96Tm8uRY_M5498QA07NPhNNzSGnQ4qhvGDPPMZCL0_3Bbu9vvp5-ZXffP_y7fLTDXdq6GeuUSFtd1pT52mLvXQKTd1FoxQeQQnQWyeU1vVnp41SCKAMtZ1Q3vl-kBfs3Tq3Bv9eqMx2DMVRjDhRWorVwyBNL1WFfIUup1IyeXvIYcT8YAXYY5O22GOTdm2y-tenwct2pN2jPlVXwdsTwOIw-oyTC-XRDb3Qre6re7-6-S7QSPY-Lbk2XP6b-2blHpPFfa4jb3-0ICQIAT3U4H9G7ZJC</recordid><startdate>20060801</startdate><enddate>20060801</enddate><creator>Paulino, N</creator><creator>Teixeira, C</creator><creator>Scremin, A</creator><creator>Dirsch, V.M</creator><creator>Vollmar, A.M</creator><creator>Abreu, S.R.L</creator><creator>Castro, S.L. de</creator><creator>Marcucci, M.C</creator><general>Thieme</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060801</creationdate><title>Evaluation of the analgesic and anti-inflammatory effects of a Brazilian green propolis</title><author>Paulino, N ; Teixeira, C ; Scremin, A ; Dirsch, V.M ; Vollmar, A.M ; Abreu, S.R.L ; Castro, S.L. de ; Marcucci, M.C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-6a4aebd66e5feba73c4a99476a31fa04106bc146676ad6944a0049e2514fcf783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>analgesic effect</topic><topic>Analgesics - isolation &amp; purification</topic><topic>Analgesics - therapeutic use</topic><topic>animal disease models</topic><topic>Animals</topic><topic>anti-inflammatory activity</topic><topic>Anti-Inflammatory Agents - isolation &amp; purification</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Apoidea</topic><topic>Biological and medical sciences</topic><topic>Brazil</topic><topic>Cell Line</topic><topic>Chromatography, High Pressure Liquid</topic><topic>cultured cells</topic><topic>Drug Evaluation, Preclinical</topic><topic>edema</topic><topic>enzyme inhibition</topic><topic>flavonoids</topic><topic>Gene Expression Regulation - drug effects</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Inflammation - drug therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>neutrophils</topic><topic>nitric oxide</topic><topic>nitric oxide synthase</topic><topic>Nitric Oxide Synthase Type II - genetics</topic><topic>Nitric Oxide Synthase Type II - metabolism</topic><topic>nitrites</topic><topic>Original Paper</topic><topic>Pain - drug therapy</topic><topic>Pharmacognosy. Homeopathy. Health food</topic><topic>Pharmacology. Drug treatments</topic><topic>Plant Extracts - administration &amp; dosage</topic><topic>Plant Extracts - isolation &amp; purification</topic><topic>Plant Extracts - therapeutic use</topic><topic>propolis</topic><topic>Propolis - administration &amp; dosage</topic><topic>Propolis - chemistry</topic><topic>Propolis - therapeutic use</topic><topic>signal transduction</topic><topic>tumor necrosis factor-alpha</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paulino, N</creatorcontrib><creatorcontrib>Teixeira, C</creatorcontrib><creatorcontrib>Scremin, A</creatorcontrib><creatorcontrib>Dirsch, V.M</creatorcontrib><creatorcontrib>Vollmar, A.M</creatorcontrib><creatorcontrib>Abreu, S.R.L</creatorcontrib><creatorcontrib>Castro, S.L. de</creatorcontrib><creatorcontrib>Marcucci, M.C</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Planta medica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paulino, N</au><au>Teixeira, C</au><au>Scremin, A</au><au>Dirsch, V.M</au><au>Vollmar, A.M</au><au>Abreu, S.R.L</au><au>Castro, S.L. de</au><au>Marcucci, M.C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the analgesic and anti-inflammatory effects of a Brazilian green propolis</atitle><jtitle>Planta medica</jtitle><addtitle>Planta Med</addtitle><date>2006-08-01</date><risdate>2006</risdate><volume>72</volume><issue>10</issue><spage>899</spage><epage>906</epage><pages>899-906</pages><issn>0032-0943</issn><eissn>1439-0221</eissn><coden>PLMEAA</coden><abstract>Abstract Phamacological activities of a standard ethanol extract G1 from Brazilian green propolis, typified as BRP1, was evaluated in mouse models of pain and inflammation. Intraperitoneal injection (I. P.) of G1 inhibited acetic acid-induced abdominal constrictions with an ID 50 = 0.75 ± 0.05 mg/kg, and in the formalin test the ID 50 values were 0.85 ± 0.07 mg/kg and 13.88 ± 1.12 mg/kg, respectively, for the neurogenic and inflammatory phases. The extract was ineffective when assessed in the hot-plate assay. In serotonin-induced paw edema, G1 led to a maximal inhibition (MI) of 51.6 % after 120 min when administered I. P. and of 36 % after 15 min by the oral route (O. R.). When the inflammatory agent was complete Freund’s adjuvant, inhibition of paw edema was also observed after administration of the extract by both routes. In the capsaicin-induced ear edema the ID 50 values were 1.09 ± 0.08 mg/kg (I. P.) and 10.00 ± 0.90 mg/kg (O. R.). In the acute carrageenan-induced inflammatory reaction induced by carrageenan, G1 reduced the number of neutrophils in the peritoneal cavity with IC 50 values of 0.72 ± 0.08 mg/kg and 4.17 ± 0.50 mg/kg, by I. P. or O. R. administration, with a preferential migration of polymorphonuclear neutrophils. IN VITRO, G1 decreased nitric oxide production in LPS-stimulated RAW 264.7 cells (IC 50 = 41.60 μg/mL), and also the luciferase activity in TNF-α-stimulated HEK 293 cells transfected with NF-κB-luciferase reporter gene driven by the nuclear factor κB (NF-κB) (IC 50 = 200 μg/mL). This extract, which at low concentrations induces anti-inflammatory and analgesic effects in mouse models, presents a high content of flavonoids, known to inhibit inducible NOS (iNOS) activity. These data taken together led us to reinforce the hypothesis in the literature that the anti-inflammatory effect of propolis may be a due to inhibition of iNOS gene expression, through interference with NF-κB sites in the iNOS promoter.</abstract><cop>Stuttgart</cop><cop>New York, NY</cop><pub>Thieme</pub><pmid>16902858</pmid><doi>10.1055/s-2006-947185</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0032-0943
ispartof Planta medica, 2006-08, Vol.72 (10), p.899-906
issn 0032-0943
1439-0221
language eng
recordid cdi_proquest_miscellaneous_68839734
source MEDLINE; Thieme Connect Journals
subjects analgesic effect
Analgesics - isolation & purification
Analgesics - therapeutic use
animal disease models
Animals
anti-inflammatory activity
Anti-Inflammatory Agents - isolation & purification
Anti-Inflammatory Agents - therapeutic use
Apoidea
Biological and medical sciences
Brazil
Cell Line
Chromatography, High Pressure Liquid
cultured cells
Drug Evaluation, Preclinical
edema
enzyme inhibition
flavonoids
Gene Expression Regulation - drug effects
General pharmacology
Humans
Inflammation - drug therapy
Male
Medical sciences
Mice
neutrophils
nitric oxide
nitric oxide synthase
Nitric Oxide Synthase Type II - genetics
Nitric Oxide Synthase Type II - metabolism
nitrites
Original Paper
Pain - drug therapy
Pharmacognosy. Homeopathy. Health food
Pharmacology. Drug treatments
Plant Extracts - administration & dosage
Plant Extracts - isolation & purification
Plant Extracts - therapeutic use
propolis
Propolis - administration & dosage
Propolis - chemistry
Propolis - therapeutic use
signal transduction
tumor necrosis factor-alpha
title Evaluation of the analgesic and anti-inflammatory effects of a Brazilian green propolis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T01%3A25%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20analgesic%20and%20anti-inflammatory%20effects%20of%20a%20Brazilian%20green%20propolis&rft.jtitle=Planta%20medica&rft.au=Paulino,%20N&rft.date=2006-08-01&rft.volume=72&rft.issue=10&rft.spage=899&rft.epage=906&rft.pages=899-906&rft.issn=0032-0943&rft.eissn=1439-0221&rft.coden=PLMEAA&rft_id=info:doi/10.1055/s-2006-947185&rft_dat=%3Cproquest_cross%3E68839734%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68839734&rft_id=info:pmid/16902858&rfr_iscdi=true